1639 related articles for article (PubMed ID: 33294831)
21. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
22. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
23. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
24. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.
Govaere O; Petersen SK; Martinez-Lopez N; Wouters J; Van Haele M; Mancina RM; Jamialahmadi O; Bilkei-Gorzo O; Lassen PB; Darlay R; Peltier J; Palmer JM; Younes R; Tiniakos D; Aithal GP; Allison M; Vacca M; Göransson M; Berlinguer-Palmini R; Clark JE; Drinnan MJ; Yki-Järvinen H; Dufour JF; Ekstedt M; Francque S; Petta S; Bugianesi E; Schattenberg JM; Day CP; Cordell HJ; Topal B; Clément K; Romeo S; Ratziu V; Roskams T; Daly AK; Anstee QM; Trost M; Härtlova A
J Hepatol; 2022 May; 76(5):1001-1012. PubMed ID: 34942286
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
[TBL] [Abstract][Full Text] [Related]
26. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
27. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.
Johnson K; Leary PJ; Govaere O; Barter MJ; Charlton SH; Cockell SJ; Tiniakos D; Zatorska M; Bedossa P; Brosnan MJ; Cobbold JF; Ekstedt M; Aithal GP; Clément K; Schattenberg JM; Boursier J; Ratziu V; Bugianesi E; Anstee QM; Daly AK; ;
JHEP Rep; 2022 Feb; 4(2):100409. PubMed ID: 35072021
[TBL] [Abstract][Full Text] [Related]
28. ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis.
Nalkurthi C; Schroder WA; Melino M; Irvine KM; Nyuydzefe M; Chen W; Liu J; Teng MWL; Hill GR; Bertolino P; Blazar BR; Miller GC; Clouston AD; Zanin-Zhorov A; MacDonald KPA
JHEP Rep; 2022 Jan; 4(1):100386. PubMed ID: 34917911
[TBL] [Abstract][Full Text] [Related]
29. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
30. Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression.
Kim AD; Kui L; Kaufmann B; Kim SE; Leszczynska A; Feldstein AE
J Mol Med (Berl); 2023 Jul; 101(7):813-828. PubMed ID: 37166517
[TBL] [Abstract][Full Text] [Related]
31. Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice.
George J; Zhang Y; Sloan J; Sims JM; Imig JD; Zhao X
Front Immunol; 2021; 12():747794. PubMed ID: 34675931
[TBL] [Abstract][Full Text] [Related]
32. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
33. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
34. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
35. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
36. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease.
Jiao J; Sanchez JI; Saldarriaga OA; Solis LM; Tweardy DJ; Maru DM; Stevenson HL; Beretta L
JHEP Rep; 2023 Feb; 5(2):100628. PubMed ID: 36687470
[TBL] [Abstract][Full Text] [Related]
37. Novel role of macrophage TXNIP-mediated CYLD-NRF2-OASL1 axis in stress-induced liver inflammation and cell death.
Zhan Y; Xu D; Tian Y; Qu X; Sheng M; Lin Y; Ke M; Jiang L; Xia Q; Kaldas FM; Farmer DG; Ke B
JHEP Rep; 2022 Sep; 4(9):100532. PubMed ID: 36035360
[TBL] [Abstract][Full Text] [Related]
38. Understanding the cellular interactome of non-alcoholic fatty liver disease.
Wallace SJ; Tacke F; Schwabe RF; Henderson NC
JHEP Rep; 2022 Aug; 4(8):100524. PubMed ID: 35845296
[TBL] [Abstract][Full Text] [Related]
39. Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.
Krenkel O; Hundertmark J; Abdallah AT; Kohlhepp M; Puengel T; Roth T; Branco DPP; Mossanen JC; Luedde T; Trautwein C; Costa IG; Tacke F
Gut; 2020 Mar; 69(3):551-563. PubMed ID: 31076404
[TBL] [Abstract][Full Text] [Related]
40. Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis.
Sun BL; Sun X; Kempf CL; Song JH; Casanova NG; Camp SM; Reyes Hernon V; Fallon M; Bime C; Martin DR; Travelli C; Zhang DD; Garcia JGN
FASEB J; 2023 Mar; 37(3):e22825. PubMed ID: 36809677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]